EX-99.1 2 a2024-q2ex991.htm EX-99.1 Document
Exhibit 99.1
snbrlogojpga.jpg
FOR IMMEDIATE RELEASE

SLEEP NUMBER ANNOUNCES SECOND QUARTER 2024 RESULTS

Generated adjusted EBITDA of $28 million for the second quarter
Delivered gross margin rate of 59.1% for the second quarter, up 150 basis points versus last year and ahead of expectations
Reduced operating expenses by $19 million year-over-year for the quarter and $44 million year-to-date (both periods before restructuring costs)
Year-to-date free cash flow increased $21 million compared with the same period last year
Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million

MINNEAPOLIS – (July 31, 2024) – Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended June 29, 2024.

“The implementation of our transformative initiatives is improving gross margin, operating expenses and free cash flow, as our teams continue to execute sustainable changes across the business. In the second quarter, we delivered gross margin rate expansion and adjusted EBITDA slightly ahead of expectations, despite facing a more challenging industry sales environment than anticipated.” said Shelly Ibach, Chair, President and CEO. “In this environment, we continue to prioritize paying down debt and reducing leverage. Our more durable operating model is enabling us to effectively navigate the persistent macroeconomic headwinds and prolonged industry recession, while positioning us for even greater profitability when the industry recovers.”

Second Quarter Overview
Net sales of $408 million were down 11% versus the prior year, including approximately six percentage points of pressure from year-over-year order backlog changes
Gross margin of 59.1% was up 150 basis points versus the prior year, driven by ongoing product cost reductions through value engineering and supplier negotiations, efficiency gains in our home delivery and logistics operations and improved product returns rates
Operating expenses of $234 million (before restructuring charges) were down $19 million versus the prior year’s second quarter, including broad-based cost reductions across the business
Adjusted EBITDA of $28 million compared to $35 million last year, with a higher gross margin rate and $19 million operating expense improvement, partially offsetting the year-over-year net sales decline

Cash Flows and Liquidity Review
Net cash provided by operating activities of $24 million for the first six months of the year, a $5 million increase versus the same period last year
Free cash flow of $9 million for the first six months of the year, up $21 million versus the same period last year
Leverage ratio of 4.4x EBITDAR at the end of the second quarter versus covenant maximum of 5.5x for the quarter

Financial Outlook
The company reiterates its outlook for 2024 adjusted EBITDA of $125 million to $145 million. We expect a mid-single digit net sales decline for the year. For the second half of the year, we expect demand and net sales to be flat to down low-single digits versus the prior year, as we lap easier comparisons from the prior year and benefit from demand driving initiatives. The company expects at least 100 basis points of gross margin rate improvement and $14 million of restructuring charges for the year. The company now expects to generate $50 million to $70 million of free cash flow with capital expenditures of $30 million.



Sleep Number Announces Second-quarter 2024 Results - Page 2 of 11    
Conference Call Information
Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. We have also posted an updated investor presentation to the investor relations area of the Sleep Number website.

About Sleep Number Corporation
Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 15 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our nearly 28 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,800 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in nearly 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number® store near you, our newsroom and investor relations sites, or SleepNumber.com

Forward-looking Statements
Statements used in this news release relating to future plans, events, financial results or performance, such as the statement that the company continues to prioritize paying down debt and reducing leverage and that the company’s more durable operating model is enabling the company to effectively navigate the persistent macroeconomic headwinds and prolonged industry recession, while positioning the company for even greater profitability, and the company’s financial outlook, including the company’s expected 2024 adjusted EBITDA and future net sales, demand, gross margin, and free cash flow expectations, are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; (414) 732-9840; julie.elepano@sleepnumber.com


Sleep Number Announces Second-quarter 2024 Results - Page 3 of 11    

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
 
Three Months Ended
 June 29,
2024
% of
Net Sales
July 1,
2023
% of
Net Sales
Net sales$408,413 100.0 %$458,789 100.0 %
Cost of sales166,923 40.9 %194,544 42.4 %
Gross profit241,490 59.1 %264,245 57.6 %
Operating expenses:
Sales and marketing182,400 44.7 %197,779 43.1 %
General and administrative39,573 9.7 %39,795 8.7 %
Research and development11,578 2.8 %15,445 3.4 %
Restructuring costs1,819 0.4 %— 0.0 %
Total operating expenses235,370 57.6 %253,019 55.1 %
Operating income6,120 1.5 %11,226 2.4 %
Interest expense, net12,270 3.0 %9,948 2.2 %
(Loss) income before income taxes(6,150)(1.5 %)1,278 0.3 %
Income tax (benefit) expense(1,099)(0.3 %)524 0.1 %
Net (loss) income $(5,051)(1.2 %)$754 0.2 %
Net (loss) income per share – basic$(0.22) $0.03  
Net (loss) income per share – diluted$(0.22) $0.03  
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding22,614  22,460  
Dilutive effect of stock-based awards—  42  
Diluted weighted-average shares outstanding22,614  22,502  

For the three months ended June 29, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.


Sleep Number Announces Second-quarter 2024 Results - Page 4 of 11    

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
 
 Six Months Ended
June 29,
2024
% of
Net Sales
July 1,
2023
% of
Net Sales
Net sales$878,862 100.0 %$985,316 100.0 %
Cost of sales361,198 41.1 %410,806 41.7 %
Gross profit517,664 58.9 %574,510 58.3 %
Operating expenses:
Sales and marketing390,912 44.5 %428,267 43.5 %
General and administrative78,652 8.9 %79,196 8.0 %
Research and development24,019 2.7 %29,888 3.0 %
Restructuring costs12,419 1.4 %— 0.0 %
Total operating expenses506,002 57.6 %537,351 54.5 %
Operating income11,662 1.3 %37,159 3.8 %
Interest expense, net24,569 2.8 %19,050 1.9 %
(Loss) income before income taxes(12,907)(1.5 %)18,109 1.8 %
Income tax (benefit) expense(374)0.0 %5,890 0.6 %
Net (loss) income$(12,533)(1.4 %)$12,219 1.2 %
Net (loss) income per share – basic$(0.56) $0.55  
Net (loss) income per share – diluted$(0.56) $0.54  
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding22,560  22,378  
Dilutive effect of stock-based awards—  165  
Diluted weighted-average shares outstanding22,560  22,543  

For the six months ended June 29, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.


Sleep Number Announces Second-quarter 2024 Results - Page 5 of 11    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Balance Sheets
(unaudited – in thousands, except per share amounts)
subject to reclassification
  
 June 29,
2024
December 30,
2023
Assets  
Current assets:
Cash and cash equivalents$2,020 $2,539 
Accounts receivable, net of allowances of $1,098 and $1,437, respectively
20,272 26,859 
Inventories95,845 115,433 
Prepaid expenses21,322 16,660 
Other current assets37,925 44,637 
Total current assets177,384 206,128 
Non-current assets:  
Property and equipment, net153,676 179,503 
Operating lease right-of-use assets373,518 395,411 
Goodwill and intangible assets, net66,523 66,634 
Deferred income taxes25,397 20,253 
Other non-current assets87,147 82,951 
Total assets$883,645 $950,880 
Liabilities and Shareholders’ Deficit  
Current liabilities:  
Borrowings under revolving credit facility$540,200 $539,500 
Accounts payable106,039 135,901 
Customer prepayments44,518 49,143 
Accrued sales returns20,531 22,402 
Compensation and benefits35,305 28,273 
Taxes and withholding16,563 17,134 
Operating lease liabilities80,914 81,760 
Other current liabilities56,500 61,958 
Total current liabilities900,570 936,071 
Non-current liabilities:
Operating lease liabilities327,810 351,394 
Other non-current liabilities102,229 105,343 
Total non-current liabilities430,039 456,737 
Total liabilities1,330,609 1,392,808 
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding
— — 
Common stock, $0.01 par value; 142,500 shares authorized, 22,355 and 22,235 shares issued and outstanding, respectively
224 222 
Additional paid-in capital24,211 16,716 
Accumulated deficit(471,399)(458,866)
Total shareholders’ deficit(446,964)(441,928)
Total liabilities and shareholders’ deficit$883,645 $950,880 



Sleep Number Announces Second-quarter 2024 Results - Page 6 of 11    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(unaudited – in thousands)
subject to reclassification
 
 Six Months Ended
 June 29,
2024
July 1,
2023
Cash flows from operating activities:  
Net (loss) income$(12,533)$12,219 
Adjustments to reconcile net (loss) income to net cash provided by
   operating activities:
Depreciation and amortization34,177 36,749 
Stock-based compensation8,109 9,890 
Net loss on disposals and impairments of assets2,500 181 
Deferred income taxes(5,144)(8,272)
Changes in operating assets and liabilities:
Accounts receivable6,587 1,903 
Inventories19,588 (7,412)
Income taxes774 1,808 
Prepaid expenses and other assets(1,483)(5,824)
Accounts payable(18,464)(10,244)
Customer prepayments(4,625)(14,683)
Accrued compensation and benefits7,153 7,594 
Other taxes and withholding(1,345)(2,074)
Other accruals and liabilities(11,776)(3,115)
Net cash provided by operating activities23,518 18,720 
Cash flows from investing activities:
Purchases of property and equipment(14,075)(29,899)
Issuance of notes receivable(2,942)(435)
Net cash used in investing activities(17,017)(30,334)
Cash flows from financing activities:
Net (decrease) increase in short-term borrowings(6,408)14,693 
Repurchases of common stock(612)(3,501)
Proceeds from issuance of common stock— 428 
Net cash (used in) provided by financing activities(7,020)11,620 
Net (decrease) increase in cash and cash equivalents(519)
Cash and cash equivalents, at beginning of period2,539 1,792 
Cash and cash equivalents, at end of period$2,020 $1,798 



Sleep Number Announces Second-quarter 2024 Results - Page 7 of 11    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Supplemental Financial Information
(unaudited)
 
 Three Months EndedSix Months Ended
 June 29,
2024
July 1,
2023
June 29,
2024
July 1,
2023
Percent of sales:    
Retail stores87.8 %87.7 %88.0 %87.4 %
Online, phone, chat and other12.2 %12.3 %12.0 %12.6 %
Total Company100.0 %100.0 %100.0 %100.0 %
Sales change rates:
Retail comparable-store sales(11 %)(20 %)(10 %)(10 %)
Online, phone and chat(13 %)(3 %)(16 %)(12 %)
Total Retail comparable sales change(11 %)(18 %)(11 %)(10 %)
 Net opened/closed stores and other
%%%%
Total Company(11 %)(16 %)(11 %)(8 %)
Stores open:
Beginning of period661 671 672 670 
Opened10 19 
Closed(19)(6)(36)(17)
End of period646 672 646 672 
Other metrics:
Average sales per store ($ in 000's) 1
$2,732 $3,089 
Average sales per square foot 1
$883 $1,007 
Stores > $2 million net sales 2
62 %71 %
Stores > $3 million net sales 2
21 %31 %
Average revenue per smart bed unit 3
$5,802 $5,990 $5,782 $5,913 

1 Trailing twelve months Total Retail comparable sales per store open at least one year.
2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.


Sleep Number Announces Second-quarter 2024 Results - Page 8 of 11    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation, restructuring costs and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:
 Three Months EndedTrailing Twelve Months Ended
 June 29,
2024
July 1,
2023
June 29,
2024
July 1,
2023
Net (loss) income$(5,051)$754 $(40,039)$11,822 
Income tax (benefit) expense(1,099)524 (10,730)6,602 
Interest expense12,270 9,948 48,214 32,289 
Depreciation and amortization16,347 18,304 69,676 71,318 
Stock-based compensation3,992 5,252 13,073 15,071 
Restructuring costs 1
1,819 — 28,147 — 
Asset impairments— 170 490 294 
Adjusted EBITDA$28,278 $34,952 $108,831 $137,396 


1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.


Free Cash Flow
(in thousands)

 Six Months EndedTrailing Twelve Months Ended
 June 29,
2024
July 1,
2023
June 29,
2024
July 1,
2023
Net cash provided by (used in) operating activities
$23,518 $18,720 $(4,230)$26,167 
Subtract: Purchases of property and equipment14,075 29,899 41,232 62,794 
Free cash flow$9,443 $(11,179)$(45,462)$(36,627)
 

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.


Sleep Number Announces Second-quarter 2024 Results - Page 9 of 11    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Net Leverage Ratio under Revolving Credit Facility
(in thousands)

Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the November 2, 2023 amendment are presented below. The prior year is presented in conformity with the November 2, 2023 amendment.
 
 Trailing Twelve Months Ended
 June 29,
2024
July 1,
2023
Borrowings under revolving credit facility$540,200 $483,800 
Outstanding letters of credit7,147 7,147 
Finance lease obligations280 361 
Consolidated funded indebtedness$547,627 $491,308 
Operating lease liabilities 1
408,724 438,483 
Total debt including operating lease liabilities (a)$956,351 $929,791 
Adjusted EBITDA (see above)$108,831 $137,396 
Consolidated rent expense110,937 112,518 
Consolidated EBITDAR (b)$219,768 $249,914 
Net Leverage Ratio under revolving credit facility (a divided by b)4.4 to 1.03.7 to 1.0
1Reflects operating lease liabilities included in our financial statements under ASC 842. The prior period has been updated to reflect this calculation.


Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.





Sleep Number Announces Second-quarter 2024 Results - Page 10 of 11    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Return on Invested Capital (Adjusted ROIC)
(in thousands)
 
Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

 Trailing Twelve Months Ended
 June 29,
2024
July 1,
2023
Adjusted net operating profit after taxes (Adjusted NOPAT)  
Operating (loss) income$(2,555)$50,713 
Add: Operating lease interest 1
27,750 27,040 
Less: Income taxes 2
(6,104)(21,993)
Adjusted NOPAT$19,091 $55,760 
  
Average adjusted invested capital
Total deficit$(446,964)$(419,141)
Add: Long-term debt 3
540,480 484,161 
Add: Operating lease liabilities 4
408,724 438,483 
Total adjusted invested capital at end of period$502,240 $503,503 
  
Average adjusted invested capital 5
$509,369 $452,573 
  
Adjusted ROIC 6
3.7 %12.3 %
1
Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.
2
Reflects annual effective income tax rates, before discrete adjustments, of 24.2% and 28.3% for June 29, 2024 and July 1, 2023, respectively.
3
Long-term debt includes existing finance lease liabilities.
4
Reflects operating lease liabilities included in our financial statements under ASC 842.
5
Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.
6
Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.
Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842.
GAAP - generally accepted accounting principles in the U.S.



Sleep Number Announces Second-quarter 2024 Results - Page 11 of 11    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Reported to Adjusted Statements of Operations Data Reconciliation
(in thousands, except per share amounts)


Three Months Ended
June 29, 2024July 1, 2023
As
Reported
Restructuring Costs 1,2
As
Adjusted
As
Reported
Operating income$6,120 $1,819 $7,939 $11,226 
Interest expense, net12,270 — 12,270 9,948 
(Loss) income before income taxes(6,150)1,819 (4,331)1,278 
Income tax (benefit) expense(1,099)431 (668)524 
Net (loss) income$(5,051)$1,388 $(3,663)$754 
Net (loss) income per share:
Basic$(0.22)$0.06 $(0.16)$0.03 
Diluted$(0.22)$0.06 $(0.16)$0.03 
Basic Shares22,614 22,614 22,614 22,460 
Diluted Shares22,614 22,614 22,614 22,502 

Six Months Ended
June 29, 2024July 1, 2023
As
Reported
Restructuring Costs 1,2
As
Adjusted
As
Reported
Operating income$11,662 $12,419 $24,081 $37,159 
Interest expense, net24,569 — 24,569 19,050 
(Loss) income before income taxes(12,907)12,419 (488)18,109 
Income tax (benefit) expense(374)2,943 2,569 5,890 
Net (loss) income$(12,533)$9,476 $(3,057)$12,219 
Net (loss) income per share:
Basic$(0.56)$0.42 $(0.14)$0.55 
Diluted$(0.56)$0.42 $(0.14)$0.54 
Basic Shares22,560 22,560 22,560 22,378 
Diluted Shares22,560 22,560 22,560 22,543 


1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.
2 The income tax expense is calculated using the estimated U.S. federal and state statutory tax rate of 23.7%.

Note - Our "as adjusted" data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates year-over-year comparisons for investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.